Cite
HARVARD Citation
Baumgartner, P. et al. (n.d.). Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope. Journal for immunotherapy of cancer. p. . [Online].